Showing results (261-270 of 5,440) with videos related to

Sort By:
Pageof 544
Bulletin Du Cancer|January 1, 1989
[Study of the clinical pharmacokinetics of fotemustine in various tumor indications]F Lokiec, K Beerblock, P Deloffre, et al.
Bulletin Du Cancer|January 1, 1989
[Carcinoma of the cervical stump. Retrospective analysis of 43 cases]G Calais, R Leloup, B Chauvet, et al.
Bulletin Du Cancer|January 1, 1989
[Esophageal cancer at the department of Calvados. Geographic and social inequality factors]D Pottier, G Launoy, L Cherie, et al.
Bulletin Du Cancer|January 1, 1989
[Clinically impalpable mammary carcinoma: morphologic and histogenetic analysis. Apropos of 114 cases]P Meynard, J Jacquemier, D Hans, et al.
Bulletin Du Cancer|September 20, 2015
What makes real world outcomes in soft tissue sarcomas? A mono-institutional trabectedin experienceGuillaume Moriceau, Alexis Vallard, Benoîte Méry, et al.
Bulletin Du Cancer|September 22, 2015
[Screening psychological distress in breast cancer patients on treatment]Benoîte Méry, Gilles-Damas Froissart, Alexis Vallard, et al.
Bulletin Du Cancer|November 20, 2015
[Genetic polymorphism of cytochrome P450 2E1 and the risk of nasopharyngeal carcinoma]Arij Ben Chaaben, Hajer Abaza, Hayet Douik, et al.
Bulletin Du Cancer|January 1, 1989
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials]M Jouve, T Palangie, L Belli, et al.
Bulletin Du Cancer|December 19, 2015
[Fertility sparing treatment in women affected by cervical cancer larger than 2cm]Juan Pablo Estevez, Delphine Hequet, Coraline Dubot, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Pageof 544